| Authors: |
Liebers N; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Department of Translational Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany., Boumendil A; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Finel H; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Edelmann D; Division of Biostatistics, German Cancer Research Center, Heidelberg, Germany., Kobbe G; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Baermann BN; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Serroukh Y; Department of Hematology, Erasmus MC Cancer Institute, University Medical Center Rotterdam, Rotterdam, the Netherlands., Blaise D; Institut Paoli Calmettes, Marseille, France., Beelen DW; University Hospital Essen, Essen, Germany., Solano C; Hospital Clinico Universitario-INCLIVA, University of Valencia, Valencia, Spain., Itälä-Remes M; University Hospital Turku, Turku, Finland., van Meerten T; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Choi G; University Medical Center Groningen, University of Groningen, Groningen, the Netherlands., Schmidt SAC; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany., Kröger N; University Medical Center Hamburg, Hamburg, Germany., Byrne J; Nottingham University, Nottingham, United Kingdom., Tudesq JJ; CHU Lapeyronie, Montpellier, France., Ossami Saidy A; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Nunes A; Kite, a Gilead Company, Santa Monica, California., Siddiqi R; Kite, a Gilead Company, Santa Monica, California., Baro E; Kite, a Gilead Company, Santa Monica, California., Zheng D; Kite, a Gilead Company, Santa Monica, California., Kloos I; Kite, a Gilead Company, Santa Monica, California., Dreger P; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France., Sureda A; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Clinical Hematology Department, Institut Català d'Oncologia-L'Hospitalet, IDIBELL, Universitat de Barcelona, Barcelona, Spain., Glass B; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France.; Department of Hematology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Dietrich S; Department of Hematology, Oncology and Clinical Immunology, University Hospital Duesseldorf, Duesseldorf, Germany.; Center for Integrated Oncology Aachen-Bonn-Cologne-Düsseldorf (CIO ABCD), Aachen Bonn Cologne Düsseldorf, Cologne, Germany.; Department of Internal Medicine V, Heidelberg University Hospital, Heidelberg, Germany.; Lymphoma Working Party, European Society for Blood and Marrow Transplantation, Paris, France. |
